ConductScience.org, home

Paper3132963

Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.

Aznar J and 6 others. Br Heart J, 1988. Cited by 182 papers, by iCite.

Cite this record

ConductScience Library. Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease. Papers, record 3132963. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3132963

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.
PubMed
Journal
Br Heart J
PubMed
Year
1988
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
182
iCite
Relative citation ratio, by iCite
6.82
iCite
Revised in PubMed
2022-03-09
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Aznar JJ
2Estellés AA
3Tormo GG
4Sapena PP
5Tormo VV
6Blanch SS
7España FF

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Coronary DiseaseMajor topic
FibrinolysisMajor topic
GlycoproteinsMajor topic
Plasminogen ActivatorsMajor topic
Plasminogen InactivatorsMajor topic
Adult
Aged
Angina Pectoris
Electrophoresis, Polyacrylamide Gel
Humans
Hyperlipidemias
Male
Middle Aged
Myocardial Infarction
Physical Exertion

Source PubMed

Download CSV of topics

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1154121The role of the fibrinolytic system in thromboembolism.Prog Cardiovasc Dis1979https://conductscience.org/library/papers/154121PubMed
24171834Fibrinolytic activity and coronary-artery disease.Lancet1968https://conductscience.org/library/papers/4171834PubMed
373215Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate.Scand J Clin Lab Invest1977https://conductscience.org/library/papers/73215PubMed
478958A study of proteases and protease-inhibitor complexes in biological fluids.J Exp Med1978https://conductscience.org/library/papers/78958PubMed
53936043The primary plasminogen-activator inhibitors in endothelial cells, platelets, serum, and plasma are immunologically related.Proc Natl Acad Sci U S A1985https://conductscience.org/library/papers/3936043PubMed
63934538Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.N Engl J Med1985https://conductscience.org/library/papers/3934538PubMed
76132131Hypertriglyceridaemia and hypercoagulability.Lancet1983https://conductscience.org/library/papers/6132131PubMed
84715196Impairment of the diurnal fibrinolytic response in man. Effects of aging, type IV hyperlipoproteinemia, and coronary artery disease.Circ Res1973https://conductscience.org/library/papers/4715196PubMed
95475635Plasminogen: purification from human plasma by affinity chromatography.Science1970https://conductscience.org/library/papers/5475635PubMed
106438106Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells.J Biol Chem1984https://conductscience.org/library/papers/6438106PubMed
116218942Plasminogen activator release during venous stasis and exercise as determined by a new specific assay.Clin Chim Acta1983https://conductscience.org/library/papers/6218942PubMed
126437481Protein C values in coronary artery disease.Br Med J (Clin Res Ed)1984https://conductscience.org/library/papers/6437481PubMed
133081778Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects.Metabolism1986https://conductscience.org/library/papers/3081778PubMed
146543037Inherited fibrinolytic disorder due to an enhanced plasminogen activator level.Thromb Haemost1984https://conductscience.org/library/papers/6543037PubMed
15854883Disordered "fibrinolytic potential" in coronary heart disease.Thromb Res1977https://conductscience.org/library/papers/854883PubMed
163092388Fibrinolytic activity and protein C in preeclampsia.Thromb Haemost1986https://conductscience.org/library/papers/3092388PubMed
177223513Hyperlipoproteinaemia and reduced fibrinolytic activity in healthy coronary high-risk men.Acta Med Scand1981https://conductscience.org/library/papers/7223513PubMed
1863141Heparin cofactor activity and antithrombin III concentration in plasma related to age and sex.Scand J Haematol1976https://conductscience.org/library/papers/63141PubMed
206446720The participation of plasma thromboplastin antecedent (Factor XI) in contact-activated fibrinolysis.Proc Soc Exp Biol Med1980https://conductscience.org/library/papers/6446720PubMed
214039134Human tissue-type plasminogen activator. Production in continuous serum-free cell culture and rapid purification.Biochem J1985https://conductscience.org/library/papers/4039134PubMed

See all 31 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 182 citations.

PMIDTitleJournalYearIn PapersSource
34222367Modest Gains After an 8-Week Exercise Program Correlate With Reductions in Non-traditional Markers of Cardiovascular Risk.Front Cardiovasc Med2021https://conductscience.org/library/papers/34222367PubMed
24068025Thrombin activatable fibrinolysis inhibitor : its role in slow coronary flow.Herz2014https://conductscience.org/library/papers/24068025PubMed
22990020Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation.Blood2012https://conductscience.org/library/papers/22990020PubMed
12373626Effects of moderate weight loss on anginal symptoms and indices of coagulation and fibrinolysis in overweight patients with angina pectoris.Eur J Clin Nutr2002https://conductscience.org/library/papers/12373626PubMed
10767109Gene Polymorphisms for PAI-1 Are Associated with the Angiographic Extent of Coronary Artery Disease.J Thromb Thrombolysis1998https://conductscience.org/library/papers/10767109PubMed
10608002Potential Antithrombotic and Fibrinolytic Properties of the Angiotensin Converting Enzyme Inhibitors.J Thromb Thrombolysis1995https://conductscience.org/library/papers/10608002PubMed
10603509Plasma Concentration of Endogenous Tissue Plasminogen Activator and the Occurrence of Future Cardiovascular Events.J Thromb Thrombolysis1994https://conductscience.org/library/papers/10603509PubMed
10597849Upright posture and maximal exercise increase platelet aggregability and prostacyclin production in healthy male subjects.Br J Sports Med1999https://conductscience.org/library/papers/10597849PubMed
9869344Fibrinolytic activity in retinal vein occlusion.Int Ophthalmol1997https://conductscience.org/library/papers/9869344PubMed
9848079Decreased fibrinolytic activity in porcine-to-primate cardiac xenotransplantation.Mol Med1998https://conductscience.org/library/papers/9848079PubMed
8364001Pharmacological control of hypertriglyceridemia.Cardiovasc Drugs Ther1993https://conductscience.org/library/papers/8364001PubMed
8254029Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis.J Clin Invest1993https://conductscience.org/library/papers/8254029PubMed
7819711Lipoprotein(a): new insights into an atherogenic lipoprotein.Clin Investig1994https://conductscience.org/library/papers/7819711PubMed
1916049Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis.Diabetologia1991https://conductscience.org/library/papers/1916049PubMed
1828764Effects of doxazosin and atenolol on the fibrinolytic system in patients with hypertension and elevated serum cholesterol.Eur J Clin Pharmacol1991https://conductscience.org/library/papers/1828764PubMed
1747294von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death.Br Heart J1991https://conductscience.org/library/papers/1747294PubMed
1516602Effect of oral defibrotide on tissue-plasminogen activator and tissue-plasminogen activator inhibitor balance.Eur J Clin Pharmacol1992https://conductscience.org/library/papers/1516602PubMed
1495992Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.Proc Natl Acad Sci U S A1992https://conductscience.org/library/papers/1495992PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
PLAT5327PubTator's text mininghttps://conductscience.org/library/genes/5327NCBI Gene
SERPINE15054PubTator's text mininghttps://conductscience.org/library/genes/5054NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3132963

GET https://conductscience.org/api/papers/v1/3132963/references?page=2